from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3714c/-

LFCtreatmentdescriptionclass of inhibitor

1.468

Amikacinug/mL Amikacintranslation

2.389

Cap5-10ug/mL Capreomycintranslation

3.925

Rox10-50 ug/mL Roxithromycintranslation

-0.196

SM2-5 ug/mL Streptomycintranslation

1.914

Tet5-10 ug/mL Tetracyclinetranslation

0.627

Rif0.2-5ug/mL Rifampicintranscription

0.250

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.519

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.066

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.052

CPZ10-50 ug/mL Chlorpromazinerespiration

0.034

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.035

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.263

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.503

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.107

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.071

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.092

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.059

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.056

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.504

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.250

KCN5-20 ug/mL Potassium cyaniderespiration

-0.216

NaN30.2-2 mM Sodium aziderespiration

-0.208

Nigericin50 uM Nigericinrespiration

-0.013

TRC10-150 ug/mL Triclosanrespiration

0.484

TRZ10-25 ug/mL Thioridazinerespiration

0.646

Valinomycin0.5-10 uM Valinomycinrespiration

-0.689

ZnSO42 mM ZnSO4respiration

1.025

menadione6-10 ug/mL Menadionerespiration

0.612

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.176

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.315

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.355

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.485

NRP_1Non-replicating persistence stage 1dosRassociated

-0.489

Amp0.2mg/mL AmpicillincellWall

-0.150

Cephalexin20-100 ug/mL CephalexincellWall

1.071

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.196

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.187

EMB10-20 ug/mL EthambutolcellWall

-0.194

Eta12-40 ug/mL EthionamidecellWall

-0.213

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.444

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.349

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.139

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.910

BZA0.12 mg/mL BenzamidearomaticAmides

-0.635

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.717

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.367

H2O24 mM hydrogen peroxideDNAdamaging

1.879

Levo10 ug/mL LevofloxacinDNAdamaging

-0.931

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.418

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.284

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.974

UVUV-irradiationDNAdamaging

1.069

ARP41-4 ug/mL Antitubercular compound ARP4?

0.443

Antimycin12.5-50 ug/mL Antimycin A?

0.338

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.119

PA_110-50 ug/mL Antitubercular compound PA-1?

0.154

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.322

PA8240.2-2 ug/mL PA-824?

0.502

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.424

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.004

Verapamil50 uM Verapamil?

0.164

mercaptoethanol2 mM 2-Mercaptoethanol?

0.308

methoxatin10-20 ug/mL Methoxatin?